BUMRUNGRAD HOSPITAL |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 253 THB | +9.52% |
|
+12.44% | +13.96% |
| Sales 2024 * | 27.25B 736M | Sales 2025 * | 29.23B 789M | Capitalization | 201B 5.43B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.42B 200M | Net income 2025 * | 7.88B 213M | EV / Sales 2024 * | 6.91 x |
| Net cash position 2024 * | 12.84B 347M | Net cash position 2025 * | 15.06B 407M | EV / Sales 2025 * | 6.37 x |
| P/E ratio 2024 * |
28.3
x | P/E ratio 2025 * |
26.7
x | Employees | - |
| Yield 2024 * |
1.95% | Yield 2025 * |
2.13% | Free-Float | 86.54% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bumrungrad Hospital
More recommendations
More press releases
| 1 day | +9.52% | ||
| 1 week | +12.44% | ||
| Current month | +12.95% | ||
| 1 month | +11.45% | ||
| 3 months | +5.42% | ||
| 6 months | -3.07% | ||
| Current year | +13.96% |
1 week
221.00
265.00
1 month
221.00265.00
Current year
220.00265.00
1 year
210.00272.00
3 years
116.50272.00
5 years
90.50272.00
10 years
90.50272.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | - | |
Oraphan Buamuang
DFI | Director of Finance/CFO | 50 | 16-02-29 |
| Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 17-10-11 | |
Prin Chirathivat
BRD | Director/Board Member | 61 | 12-02-26 |
| Chairman | 80 | 78-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.07% | 2,808 M€ | +4.23% | - | |
| 0.07% | 441 M€ | +3.59% | - | |
| 0.07% | 149 M€ | +0.93% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 253 | +9.52% | 20 181 790 |
| 24-04-24 | 231 | +1.76% | 1,816,542 |
| 24-04-23 | 227 | +0.89% | 2,893,068 |
| 24-04-22 | 225 | +0.45% | 1,544,895 |
| 24-04-19 | 224 | 0.00% | 2,594,024 |
End-of-day quote Thailand S.E., April 24, 2024
More quotes
Bumrungrad Hospital Public Company Limited is a healthcare provider in Thailand and Southeast Asia, providing holistic and healthcare services for both outpatients and inpatients. The Company operates through a hospital and health care center business. It operates a private hospital business in Bangkok with 580 licensed beds and a capacity for over 5,500 outpatients per day. Its Telemedicine service provides consultation through information technology to support remote access consultation. Its preventive genomics and family check-up services provide diagnosis, treatment, and advice, including risk assessment and screening for diseases caused by genetic abnormalities. Its Bumrungrad@Home service provides health care services for patients and families at their homes as necessary. Its Breast Center delivers holistic medical services regarding breast health for all genders. Its sports medicine and joint center offer an integrated approach to treating musculoskeletal problems.
Calendar
2024-04-24
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
253
THB
Average target price
285.2
THB
Spread / Average Target
+12.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.96% | 4.96B | |
| -14.73% | 85.42B | |
| +16.05% | 84.38B | |
| +10.92% | 29.39B | |
| -12.73% | 17.49B | |
| -3.17% | 16.44B | |
| -1.78% | 15.28B | |
| -0.45% | 12.22B | |
| -31.23% | 11.98B | |
| -2.51% | 11.71B |
- Stock Market
- Equities
- BH Stock
